{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=10+mL+preservative+free+saline&page=2", "query": { "intervention": "10 mL preservative free saline", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 32, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=10+mL+preservative+free+saline&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=10+mL+preservative+free+saline&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-05T03:01:46.630Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04305743", "title": "Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Urinary Bladder, Overactive", "Incontinence, Urge", "Incontinence, Urinary", "Urinary Urge Incontinence", "Urinary Frequency More Than Once at Night", "Nocturia" ], "interventions": [ { "name": "OnabotulinumtoxinA 100 UNT", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of South Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 60, "start_date": "2019-10-09", "completion_date": "2021-06-01", "has_results": false, "last_update_posted_date": "2020-11-05", "last_synced_at": "2026-10-05T03:01:46.630Z", "location_count": 2, "location_summary": "Washington D.C., District of Columbia • Tampa, Florida", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04305743" }, { "nct_id": "NCT02473198", "title": "Femoral Nerve Block Compared to Exparel in Total Knee Replacement", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Osteoarthritis", "Pain" ], "interventions": [ { "name": "Exparel", "type": "DRUG" }, { "name": "Femoral Nerve Block Bupivacaine", "type": "DRUG" }, { "name": "Toradol", "type": "DRUG" }, { "name": "Morphine Sulfate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The New England Baptist Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "73 Years", "sex": "ALL", "summary": "18 Years to 73 Years" }, "enrollment_count": 312, "start_date": "2014-01", "completion_date": "2017-02", "has_results": false, "last_update_posted_date": "2016-03-17", "last_synced_at": "2026-10-05T03:01:46.630Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02473198" }, { "nct_id": "NCT05289037", "title": "COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "AS03", "type": "DRUG" }, { "name": "BNT162b2", "type": "BIOLOGICAL" }, { "name": "BNT162b2 (B.1.1.529)", "type": "BIOLOGICAL" }, { "name": "BNT162b2 (B.1.351)", "type": "BIOLOGICAL" }, { "name": "BNT162b2 bivalent (wildtype and Omicron BA.1)", "type": "BIOLOGICAL" }, { "name": "BNT162b2 bivalent (wildtype and Omicron BA.4/BA.5)", "type": "BIOLOGICAL" }, { "name": "CoV2 preS dTM [B.1.351]", "type": "BIOLOGICAL" }, { "name": "CoV2 preS dTM/D614", "type": "BIOLOGICAL" }, { "name": "CoV2 preS dTM/D614+B.1.351", "type": "BIOLOGICAL" }, { "name": "mRNA-1273", "type": "BIOLOGICAL" }, { "name": "mRNA-1273.351", "type": "BIOLOGICAL" }, { "name": "mRNA-1273.529", "type": "BIOLOGICAL" }, { "name": "mRNA-1273.617.2", "type": "BIOLOGICAL" }, { "name": "Sodium Chloride, 0.9%", "type": "OTHER" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1270, "start_date": "2022-03-30", "completion_date": "2023-11-27", "has_results": true, "last_update_posted_date": "2025-10-20", "last_synced_at": "2026-10-05T03:01:46.630Z", "location_count": 22, "location_summary": "Birmingham, Alabama • San Diego, California • San Francisco, California + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05289037" }, { "nct_id": "NCT02097121", "title": "OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Urinary Incontinence", "Urinary Bladder", "Overactive" ], "interventions": [ { "name": "BOTOX®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 56, "start_date": "2014-05-23", "completion_date": "2022-02-10", "has_results": true, "last_update_posted_date": "2022-12-28", "last_synced_at": "2026-10-05T03:01:46.630Z", "location_count": 8, "location_summary": "Anchorage, Alaska • Little Rock, Arkansas • Aurora, Colorado + 5 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Aurora", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02097121" }, { "nct_id": "NCT02292082", "title": "The Combination of Adductor Canal Block and Periarticular Injection. A Novel Technique for Patients Undergoing Total Knee Replacement (ACB PAI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Osteoarthritis" ], "interventions": [ { "name": "Bupivacaine", "type": "DRUG" }, { "name": "Morphine", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Cefazolin", "type": "DRUG" }, { "name": "Normal saline", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" }, { "name": "Propofol", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "8 MHz. Chiba needle, 22 G / 4 inches", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Hospital for Special Surgery, New York", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 111, "start_date": "2014-11", "completion_date": "2016-08", "has_results": true, "last_update_posted_date": "2019-01-11", "last_synced_at": "2026-10-05T03:01:46.630Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02292082" }, { "nct_id": "NCT00955877", "title": "Extended-release Epidural Morphine for Acute Post-operative Analgesia Following Selective Dorsal Rhizotomy in Children", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Spastic Cerebral Palsy" ], "interventions": [ { "name": "Extended-release Epidural morphine (EREM) 80", "type": "DRUG" }, { "name": "Extended-release Epidural Morphine (EREM) 120", "type": "DRUG" }, { "name": "Control: Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "2 Years to 12 Years" }, "enrollment_count": 13, "start_date": "2010-03", "completion_date": "2015-01", "has_results": true, "last_update_posted_date": "2018-07-11", "last_synced_at": "2026-10-05T03:01:46.630Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00955877" }, { "nct_id": "NCT01137669", "title": "ZOSTAVAX® in Renal Transplant Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Herpes Zoster" ], "interventions": [ { "name": "Live attenuated herpes zoster vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 34, "start_date": "2010-09", "completion_date": "2015-02", "has_results": false, "last_update_posted_date": "2017-01-09", "last_synced_at": "2026-10-05T03:01:46.630Z", "location_count": 3, "location_summary": "Iowa City, Iowa • Baltimore, Maryland • Nashville, Tennessee", "locations": [ { "city": "Iowa City", "state": "Iowa" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01137669" }, { "nct_id": "NCT05046639", "title": "Sciatic Block in Contralateral Limb Phantom and Residual Limb Pain", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pain", "Amputation" ], "interventions": [ { "name": "10 mL 2% lidocaine", "type": "DRUG" }, { "name": "10 mL preservative free saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2021-09-01", "completion_date": "2023-07-26", "has_results": true, "last_update_posted_date": "2025-03-03", "last_synced_at": "2026-10-05T03:01:46.630Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05046639" }, { "nct_id": "NCT05482321", "title": "Pancreas Ultrasound Imaging in type1 Diabetes", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Type1diabetes", "Insulitis", "Pancreas Inflamed" ], "interventions": [ { "name": "Definity Suspension for Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 50, "start_date": "2023-02-27", "completion_date": "2026-09", "has_results": false, "last_update_posted_date": "2026-05-06", "last_synced_at": "2026-10-05T03:01:46.630Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05482321" }, { "nct_id": "NCT01043211", "title": "Analgesic Efficacy of Intravenous Lidocaine for Postoperative Pain Following Adult Spine Surgery", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Back Pain" ], "interventions": [ { "name": "Lidocaine Hydrochoride Injection, without epinephrine", "type": "DRUG" }, { "name": "Normal Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "19 Years to 80 Years" }, "enrollment_count": 0, "start_date": "2012-01", "completion_date": "2014-03", "has_results": false, "last_update_posted_date": "2015-03-10", "last_synced_at": "2026-10-05T03:01:46.630Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01043211" } ] }